Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578


News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Sanofi : Muzammil Mansuri is Sanofi’s new Executive Committee member

02/05/2016 | 04:30pm US/Eastern

Sanofi has announced the appointment of Muzammil “Muz” Mansuri as a new member of the Executive Committee.

Mr. Mansuri joins Sanofi from Gilead Sciences and will take the position of Executive Vice President, Strategy & Business Development. He will be responsible for all Group strategic planning, business development, strategic intelligence, alliance management and the Sanofi Genzyme Bio Ventures fund.

Commenting on the appointment, Olivier Brandicourt, CEO, Sanofi, said: “Muz brings a wealth of experience as a senior executive within the global biopharmaceutical industry.Muz’s deep understanding of business development and strategy of global biopharmaceutical organizations will allow him to contribute significantly to the overall Group strategy and make him a valuable addition to Sanofi and the Executive Committee.”

Mr. Mansuri has more than 35 years of experience beginning in 1981 with Shell Research Limited where he began as a research scientist. After Shell, he spent several years with Bristol-Myers Company in various R&D roles with increasing responsibility. From 2007 to 2010, he was Chairman and CEO at CGI Pharmaceuticals. Mr. Mansuri’s most recently was Senior Vice President, Research & Development Strategy and Corporate Development at Gilead Sciences.

Mr. Mansuri holds a Bachelor of Science degree in Chemistry and a Ph.D in Organic Chemistry from the University College London. He held post-doctoral positions at the University of California, Los Angeles (UCLA) and Columbia University.

© Russell Publishing Limited, 2016. All Rights Reserved., source Trade Journals

React to this article
Latest news on SANOFI
02/05 SANOFI : Muzammil Mansuri is Sanofi’s new Executive Committee member
02/05 SANOFI : Zealand clarifies its role in US patent litigation relating to lixisena..
02/05DJSanofi SA 4Q 2015 -- Forecast
02/05 SANOFI : Appoints Muzammil Mansuri to Executive Committee and Executive Vice Pre..
02/04 SKYEPHARMA : Mundipharma Appointed as Development and Marketing Partner for flut..
02/04 SANOFI : Researchers from Sanofi Aventis Report New Studies and Findings in the ..
02/04 SANOFI : Vemedia Group to Acquire Laboratoire Oenobiol from Sanofi
02/03 SANOFI : Begins zika virus vaccine research
02/03 SANOFI : Zika virus facts you need to know
02/03 SANOFI : Drug firm starts work on Zika vaccine
News chart
Full-screen chart
Income Statement Evolution
More Financials